The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial

Cancer Epidemiology Biomarkers and Prevention

Volumn 10, Issue 8, 2001, Pages 823-829

  Khuri, Fadlo R ^a,b   Kim, Edward S ^a   Lee, J Jack ^a   Winn, Rodger J ^a,e   Benner, Steven E ^a   Lippman, Scott M ^a,c   Fu, Karen K ^b   Cooper, Jay S ^b   Vokes, Everett E ^b,d   Williams, Brendell ^a,e   Pajak, Thomas F ^b   Goepfert, Helmuth ^a,b   Hong, Waun K ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b RADIATION THERAPY ONCOLOGY GROUP   (United States)

^c Southwest Oncology Group   (United States)

^d Cancer and Leukemia Group B   (United States)

^e Pre clinical Neuro oncology Research Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTININE; ISOTRETINOIN; RETINOID;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; PHARYNX CANCER; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SECOND CANCER; SMOKING; SQUAMOUS CELL CARCINOMA; TOBACCO;

ADULT; AGED; CHEMOPREVENTION; COTININE; DERMATOLOGIC AGENTS; DOUBLE-BLIND METHOD; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INCIDENCE; ISOTRETINOIN; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; SMOKING;

EID: 0034896936     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Cancer statistics, 2000
2. Head and neck cancer
3. Head and neck cancer
4. Changing patterns of failure in advanced head and neck cancer
5. Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids)
6. Tissue changes following deprivation of fat-soluble A vitamin
7. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck
8. Prevention of second primary tumors with isotretinoin in patients with squamous cell carcinoma of the head and neck: Follow-up
9. Outcomes of a placebo run-in period in a head and neck chemoprevention trial
10. The use of a run-in to enhance compliance
11. Adherence management in long-term clinical trials for prevention
12. Multiple primary malignant tumors: A survey of the literature and statistical study
13. Misclassification of smoking status in the CARDIA study: A comparison of self-report with serum cotinine levels
14. Factors associated with discrepancies between self-reports on cigarette smoking and measured serum cotinine levels among persons aged 17 years or older: Third National Health and Nutrition Examination Survey, 1988-1994
15. Human papillomavirus and p53 oncoprotein in verrucous carcinoma of the larynx
16. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers
17. Genetic progression model for head and neck cancer: Implications for field cancerization
18. Distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma
19. Multiple head and neck tumors: Evidence for a common clonal origin
20. Genetic progression and clonal relationship of recurrent premalignant head and neck lesions
21. The origins of multiple squamous cell carcinomas in the aerodigestive tract
22. EUROSCAN, a randomized trial of vitamin a and N-acetylcysteine in patients with head and neck cancer or lung cancer
23. Tobacco smoking, alcohol drinking and dietary factors as determinants of new primaries among male laryngeal cancer patients: A case-cohort study
24. Second primary cancers related to smoking and treatment of small-cell lung cancer
25. Regulation of retinoid signalling by receptor polarity and allosteric control of ligand binding
26. Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease
27. Smoking cessation after successful treatment of small-cell lung cancer is associated with fewer smoking-related second primary cancers
28. Tobacco usage in patients with head and neck carcinomas: A follow-up study on habit changes and second primary oral/oropharyngeal cancers
29. Influence of continued smoking on the incidence of second primary cancers involving mouth, pharynx, and larynx
30. Second primary cancers in patients with laryngeal cancer: A population-based study
31. A comparison of sustained-release bupropion and placebo for smoking cessation
32. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation
33. Phase II study of biologic adjuvant therapy to prevent recurrence and second primary tumors (SPT) in stage III/IV head and neck cancer